Contraceptive Pills Brand Ranking

Bayer HealthCare

Yosmin® (drospirinone ethinylestradiol tablets) is a short-acting birth control pill containing the unique progesterone drospirinone, and the indication is for female contraception. Yosimedrspirinone ethinylestradiol tablets - a new generation of oral short-acting contraceptive pills, German quality, produced by Bayer, specially designed for modern women. Yousming contains drospirenone ingredients, one tablet per day, low dose, fast metabolism, and takes 21 consecutive days, routine contraception, making it more convenient to use!

Ningbo Yaoming Medical Technology Co., Ltd.

Ningbo Yaoming Medical Technology Co., Ltd. is located in Ningbo City, Zhejiang Province, on the coast of the East China Sea.Yaoming Medical Technology Company has always prioritized research and innovation as its foundation, sales channels as its basis, digital solutions as its guide, and clinic terminal demands as its orientation. The company adheres to the principles of scientific development and people-oriented approach, boasting a comprehensive management team, robust technical team, stable sales team, and distribution channels.lt has established deep collaborations with relevant hospitals, frontline doctorsand universities, among others, to enhance the "industry-university-research-application" independent innovation model and foster synergistic innovation to empower industry development.Yaoming Medical has always been at the forefront of exploration in the field of minimally invasive surgical instruments and accessories(MISIA),particularly in the MISIA market.With a focus on products such as carbon dioxide insufflators and disposable sterile trocar systems for laparoscopic insufflation,we has achieved significant breakthroughs in technology after long-term research and development efforts.It has successfully overcome technological barriers from foreign sources and pioneered the development of a brand-new laparoscopic insufflation system. After multiple rounds of testing, the performance of the system is on par with high-end foreign products.We has always been dedicated to technological innovation, aiming to provide excellent and comprehensive solutions in the field of minimally invasive surgical instruments for doctors and patients alike.lts commitment extends to expanding the path of the global minimally invasive surgical medical deviceindustry in China.

Longkou Kangxie Medical Instrument Co., Ltd

we are a high-tech enterprise specializing in the research, production and sales of X-ray protection products. The company occupies an area of 8,000 square meters, well-equipped, complete testing, with strong technical energy, owns 120 employees including 30 engineering and technical personnel, the company was established in 2006, the production products include: medical X-ray protection products, medical X-ray protection Skirts, protective gloves, protective screens, protective chairs, protective glasses, protective masks, traction straps, medical oxygen bags, medical air cushions, anal bags, etc.

Jirui Pharmaceuticals (China) Co., Ltd.

Postinor® is the world's earliest oral emergency contraceptive that only contains progesterone. It is the original product of levonorgestrel and is also a reference preparation for domestic consistency evaluation. In 1979, Postinor® was successfully developed by Jirui Pharmaceutical Factory and was launched in Europe. In 1998, Postinor® was identified by the WHO as the world's first emergency contraceptive pill. Postinor® is best sold in more than 100 countries and regions around the world, with more than 500 million use experiences, verifying the safety and effectiveness of Postinor®.

Guangzhou Langsheng Pharmaceutical Co., Ltd.

Guangzhou Langsheng Pharmaceutical Co., Ltd. was established in 2003. It is a high-tech pharmaceutical company focusing on the research, development, production and sales of reproductive health drugs, chronic disease drugs, and external medicines. It adheres to the principle of "making human reproduction healthier" The company's mission focuses on family planning, perinatal period, ED and other fields with more than 30 innovative drugs and medical devices at different R&D stages, including birth control pills, mifepristone tablets, misoprostol vaginal tablets, tadalafil tablets , sildenafil tablets, condoms, ovulation tests and other products. After 18 years of continuous development, it has now become an excellent enterprise in the field of reproductive health in China. Langsheng Pharmaceutical implements a group development model, with multiple subsidiaries (Guangzhou Wanfangjian Pharmaceutical Co., Ltd., Guangzhou Shiao Trading Co., Ltd., Jiangsu Langsheng Pharmaceutical Co., Ltd., etc.), in Guangzhou, Jiangsu, Shaoguan and other places It has multiple production bases and has recently launched a number of products. It is now in a period of rapid development and requires continuous replenishment of fresh blood. Langsheng Pharmaceutical is defined as a modern pharmaceutical company driven by R&D and market-led, focusing on R&D and marketing. Since its establishment, Langsheng Pharmaceutical has always adhered to independent product research and development, and has been recognized as the "Guangdong Reproductive Health Engineering Technology Research Center", "Guangdong Province Intellectual Property Demonstration Enterprise", and "National Intellectual Property Advantage Enterprise". It has many excellent R&D personnel and complete R&D platform. With its strong scientific research strength, Langsheng Pharmaceutical has a number of independently developed products. Among them, Danmei has won the "Healthy China Brand List·Sharp List" many times with her "entertainly coated" patent; Akatsuki successfully obtained the "Bill Gates Fund" by developing condoms with a thickness of less than 30 microns or even 25 microns. Gradually developed into a well-known domestic condom brand. Recently, the company has launched a number of new products: Chilu® sildenafil, Chilu® Tadalafil, Sumi® Misoprostol vaginal tablets, and other products to be launched soon will gradually realize male reproductive health, Women use medicines in the whole reproductive health field from contraception to pregnancy to postpartum care. In order to better promote corporate product marketing and shape brand image, Langsheng Pharmaceutical has established offices in Beijing, Guangzhou, Tianjin and other places, and has built a marketing team covering provinces across the country, through various channels such as OTC, HCP, and online shopping platforms. Combined marketing model, provide complete and high-quality supply services. While focusing on the domestic market, the company has turned its attention overseas. After successfully obtaining EU CE certification, it has sold its products to Europe, the United States and other countries.

Shandong Zhushi Pharmaceutical Group Co.,LTD

Shandong Zhushi Pharmaceutical Group is located in China. It has been in the industry of Medical Devices for over 20 years now. Our company presents innovative products to you that including Medical Devices (Epidemic Prevention Products, Medical consumables, Medical Plaster & Medical Gel Products), Skin Care and Cosmetics, Health Food Products, etc.

Northeast Pharmaceutical Group Co., Ltd.

Anting Tablets, also known as levonorgestrel tablets, are contraceptive drugs and are used for emergency contraception in women, that is, when there is no protective measures or other contraceptive methods accidentally make mistakes. 【Ingredients】 Each tablet of this product contains 0.75 mg of main ingredient levonorgestrel. The auxiliary materials are lactose, starch, sucrose, sodium carboxymethyl starch, talc, and magnesium stearate. 【Properties】This product is a white piece. [Usage and Dosage] Take oral, take the first tablet within 72 hours after sex, and take the second tablet after 12 hours.

Organon (Shanghai) Pharmaceutical Technology Co., Ltd.

Mafulong is the leader in modern world's short-acting contraceptive pills. It has a history of many years and is highly contraceptive. It is a safe choice for lovers in 97 countries around the world, helping you stay away from the worries of unexpected pregnancy. In 1994, Mafulong oral contraceptives were brought to China by the Netherlands Oganan Pharmaceutical Company. Mafulong entered Europe in 1981 and has now become one of the widely used oral contraceptive brands in the world. Ma Fulong has good contraception effect. Because of its unique progesterone components, Ma Fulong overcomes the androgenic side effects of domestic oral contraceptives in the past, and the incidence of other side effects is very low. In developed countries in Europe and the United States, the use rate of oral contraceptives in women of childbearing age has always been relatively high. Currently, about 75 million women worldwide are taking MaFL, which is widely used. It was approved by the U.S. Food and Drug Administration (FDA) in 1992. Best sold in 114 countries and regions around the world. As of 1998, Mafulong's global sales have exceeded 900 million boards.

Zhejiang Xianju Pharmaceutical Co., Ltd.

Zhejiang Xianju Pharmaceutical Co., Ltd. (stock code: 002332) was formerly the Xianju Pharmaceutical Factory. It was founded in 1972. The company has fulfilled the corporate mission of "your health and happiness, my sincerity and responsibility" to "become the whole world. The top ten steroid drug suppliers have become popular among customers and employees. "For the development vision, they focus on the field of steroid hormones. The company's total share capital is RMB 989.204866 million, and currently has more than 3,600 employees. The company is a key high-tech enterprise in the National Torch Program, and has a Zhejiang Steroid Drug Engineering Technology Research Center and a national postdoctoral workstation. Ranked 67th on the top 100 Chinese pharmaceutical industry enterprises in 2020. The company has unique products and adheres to the integrated business model of raw materials and preparations. Its main business is the development, production and sales of steroidal raw materials and preparations. Product research and development closely focuses on the four major therapeutic areas (gynecology, anesthesiology, respiratory and dermatology). The company has established long-term cooperative relationships with more than 20 well-known domestic scientific research institutes (schools) including the Shanghai Institute of Organics of the Chinese Academy of Sciences, Zhejiang University, and China Pharmaceutical University, recruited senior scientific research talents, and gradually connected with international new drug development. The company has initially formed a technical architecture system with professional foreign R&D institutions as the source, Hangzhou and Xianju Research Institutes as the digestion and acceptance, and Xianju Base as the implementation. The company's subsidiaries include 20 wholly-owned and controlled subsidiaries including Taizhou Xianju Pharmaceutical Co., Ltd. It has three core manufacturing platforms in China: Xianju Yangfu Raw Materials Production Zone, Xianju Yangfu Preparation Production Zone, and Linhai South Sichuan Production Zone. It has two standardized Raw Materials Factory abroad, mainly based on its Italian subsidiary NewChem. Xianju Pharmaceutical advocates real culture, win-win culture and innovative culture, and upholds the core corporate values ​​of "integrity, hard work, openness, learning, responsibility, and win-win". The company adheres to the strategic concept of achieving win-win results in customers, enterprises, employees, society, etc., and advocates the value concept that personal value is reflected in the process of realizing corporate value and social value. In the future development process, the company will continue to improve the management level of the enterprise, continuously develop high-tech products, give full play to the scale effect, promote the high-quality development of the enterprise, and contribute to the cause of human health.

Guangzhou Vantee Electronic Technology Co., Ltd.

Founded in year 2015, specialized in the medical beauty equipment line, especially the Micro Needling system, years of professional experience help us master the high level quality product, more with the good service. Here we creates Essenlite Pen,Essenlite Needle,Finer Roller,Finer Stamp,Finer Needle brands for each kinds of derma pen, needle cartridges,derma roller, and hydra stamp.Compay is qualified with Medical device produce licence, clean produce workshop,normative material stock, and constant temperature humidity store room,as well as the skillful and trained production worker. Research from the basic materials to the product structure, design the fashion appearance, create the efficient manufacturing techniques, help make the popular products and meet the different customers demands. Now the company owns two sets NC-disk molding machines, four sets NC- injection molding machines, two sets semi – automatic assemble devices, as well as the packaging equipment. And here is the CNC center to make kinds of aluminium components and parts,specially for the dermapen, or other aluminium products. R&D and quality control according to ISO13485, certificate standards according to EU medical CE( MDR), electrical safety standards cooperate with SGS and meet directions IEC60601, hazardous substances meet demands of RoHS and SFDA, sterilization according to ISO11135. Products have already been registered in Europe (CIBG), and appoint SUNGO Europe B.V as the European Authorized Representative. On Brazil market, the products approved by ANVISA and INMETRO.On Middle East market, company and all products are registered in Egypt. It is a great honor for us to cooperate with you and create a new day.

China Resources Pharmaceutical Holdings Company Limited

China Resources Zizhu Pharmaceutical Co., Ltd., formerly known as the Beijing Third Pharmaceutical Factory established in 1969, was restructured into Beijing Zizhu Pharmaceutical Co., Ltd. in 1999 and became a wholly-owned subsidiary of China Resources Pharmaceutical Group in 2012. China Resources Zizhu has more than 50 years of experience in R&D and production of women's health drugs. It is one of the backbone enterprises of the vice president unit of the China Reproductive Health Industry Association, a national high-tech enterprise, a national green factory, and a leapfrog development project of Beijing Biopharmaceutical Industry (G20 project). The company has provincial R&D platforms such as Beijing Reproductive Contraceptive Drug Engineering Technology Research Center and Beijing Enterprise Technology Center. China Resources Zizhu continues to enrich its business development ideas, oriented towards women's health needs, and focuses on sub-sectors. It has now formed a scientific multi-product series combination, with women's health medicines and devices, oral medicines, ophthalmic medicines, diabetes medicines, raw materials medicines, latex The product line of business and other products is a supplier of reproductive health drugs from the United Nations Population Fund. The series of family planning drugs have always occupied an important position in the domestic and international markets since they were launched.

Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd.

Xinyi brand, founded in 1916, is currently 100% wholly-owned by Shanghai Pharmaceutical Group Co., Ltd. and is a larger industrial manufacturing enterprise under Shanghai Pharmaceutical Group. As a national pharmaceutical enterprise with a century-old history, Shangyao Xinyi mainly undertakes the social responsibilities of national drug emergency reserves, supporting the state and local governments to promote medical reform, and support social welfare undertakings. At present, Xinyi has become one of the industrial entities with a complete range of product varieties and dosage forms in China. It has 11 major industrial enterprises, 2 major commercial companies, 1 procurement center, a municipal R&D center, and 2 joint ventures, with product approval documents Nearly 1,000, involving 14 major therapeutic areas, covering 20 dosage forms, and there are 2 countries with Class I new drug varieties. There are 405 sales specifications (of which 149 varieties and 270 products have entered the newly issued basic medicine catalogue of the state, accounting for nearly half of the chemical basic medicine catalogue). On the basis of maintaining the competitive advantages of chemical preparations, Xinyi has established the leading position of microecological preparations in the country, as well as four special dosage forms: aerosols, eye drops, soft capsules, and slow-release preparations. In 2011, Peficon was selected as the "national standard strain" of microecological preparations and was awarded the US ATCC standard strain in 2016. Currently, it is applying for registration as an independent intellectual property product in the United States FDA. Since 1999, Xinyi has launched a large-scale public welfare activity "Millions of Citizens See Pudong and Xinyi", which has continued to promote science and health concepts for 19 years, with 520,000 beneficiaries.

Changzhou Weipu Medical Devices Co., Ltd.

Changzhou Weipu Medical Devices Co., Ltd. is located in Xinbei District Changzhou City, in the Golden Triangle of the Yangtze River, here we have superior geographical location and convenient transportation.The company covers an area of over 20000 square meters and is dedicated to the research and development, production, sales, and service of medical devices. As one of the largest OEM manufacturer in China, we achieve full inspection of each product and specification, with a large workload every time. We have a strong commitment to healthcare professionals, and we are proving it every day. Although it is time-consuming and labor-intensive, and increases costs, the quality reputation of Weipu brand has won recognition from the market and customers. Our company adheres to the corporate philosophy of "customer first, technological innovation, reliable quality", and has a large number of professional talents, laying a solid foundation for the company to continuously surpass and pursue better goals. The company actively follows the ISO13485 quality management system, strictly manages quality, ensures product quality, provides trustworthy products for users, and receives recognition from the majority of users with the most thoughtful service. Healthcare professionals inspire our wound management, prevention and surgical solutions. Their relentless search for new and better ways to care for patients drives us to innovate. And the research and development of new products is the source of maintaining a company's market advantage and competitiveness. Therefore, we always insist on paying tribute to life with innovation, patient safety first and clinical effect first.

WanHua Puman Bioengineering Co., Ltd.

Wanhua Puman Bioengineering Company is a wholly-owned American enterprise established in Beijing in 1993 with the approval of the Ministry of Economic and Trade and the State Administration of Industry and Commerce. It is mainly engaged in the research, development and production of bioengineering diagnostic products. It has a Shenyang Branch and Chengdu Branch. The company, Shanghai branch, Guangdong office and other branches. Wanhua Company became a foreign-funded enterprise that introduced diagnostic reagents for early pregnancy monoclonal antibodies in 1993. With the company's good development, by 1996, the company's development of products increased to four major categories: early pregnancy, ovulation, stool hiccups, and drugs. In order to align with advanced international enterprises, the company passed the ISO9001 quality system certification in 2000 and the CE certification in European quality system in 2002. In order to strengthen the quality management of the enterprise, the company organizes two internal audits and one external audit every year. Due to domestic and foreign market demand, especially in line with international standards after joining the WTO, the company has passed the GMP certification work in February 2006 according to the relevant regulations on the management of national pharmaceutical manufacturing enterprises.

China Resources Pharmaceutical Holdings Co., Ltd.

Yuting is a brand under China Resources Zizhu Pharmaceutical, a leading domestic emergency contraception brand. It is a large pharmaceutical company focusing on the development and production of family planning drugs. It has successively launched a series of products such as contraceptive pills, ovulation test strips, early pregnancy test strips, condoms, etc. The company's leading product, the emergency contraceptive pill "Yuting" and the anti-premature pregnancy pill "mifepristone", have received good domestic market response after it was launched, and it has been registered in more than 20 countries or regions.

NINGBO RAYCAREMED MEDICAL INSTRUMENTS CO., LTD

Ningbo Raycaremed Medical Instruments Co.,Ltd is one of the professional supplier for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory ,located in Jiangsu province,which near Shanghai port, we produce Syringe, infusion set, Gloves and Face mask. In order to fulfill and increasing needs of our trusted and loyal customers,apart from our factory ,we have more than 5 strategic partners which produce urine bags, surgical gowns, medical tubes, wound dressing syringes diagnostics & lab products. We care the success of our customers,we know that the important of quality,so we set up a strong QC team stay in differences production lines to ensure & control quality. Our Company is approved by CE&ISO certificates for most of products. In future, Raycaremed Medical will keep high effcient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.

Renfu Pharmaceutical Group Co., Ltd.

Renfu Pharmaceutical Group Co., Ltd. was established in 1993 and listed on the Shanghai Stock Exchange in 1997. It is the leading pharmaceutical industry enterprise in Hubei Province's National Enterprise Technology Center, a national technological innovation demonstration enterprise, and a leading enterprise in the internationalization of Chinese pharmaceutical enterprise preparations. Domestic narcotic drugs, steroid hormone drugs, Uyghur ethnic medicines have established a leading position in many sub-sectors. The company is mainly based on the pharmaceutical industry and supplemented by the pharmaceutical business, and is steadily promoting internationalization. The pharmaceutical industry has achieved full dosage form production capacity of pharmaceutical intermediates-raw materials-pharmaceutical excipients-pharmaceutical preparations in the entire industry chain; pharmaceutical business adheres to the positioning of "comprehensive medical service supplier", lays out commercial networks, and achieves full regional coverage; internationalization has formed The full value chain capability of pharmaceuticals for global R&D, registration, production and sales has been exported to more than 80 products in more than 70 countries and regions around the world. Based on innovative drugs, innovative preparations and high-end generic drugs with high clinical value, the company aims at cutting-edge fields and creates a first-class innovative R&D industrialization platform. R&D centers have been set up in Wuhan, Yichang, China, New Jersey, St. Louis and other places in the United States. The group has more than 500 projects under development, including more than 30 new drugs in Class I, and has obtained 778 authorized patents. Renfu Pharmaceutical firmly adheres to the development strategy of "being a leader in the pharmaceutical market segment". Through the three strategic paths of "focusing, innovation, and internationalization", it gradually realizes the leap from international follow-up to leading, and creates global competitiveness. a world-class pharmaceutical company.

Sinopharm Group Co., Ltd.

Shanghai Modern Pharmaceutical Co., Ltd. (hereinafter referred to as "Sino Pharmaceutical Modern") was established in 1996. It is a high-tech enterprise in the pharmaceutical industry founded by an academician of the Chinese Academy of Engineering and specializing in the research, development, production and sales of pharmaceutical products. The company was listed on the Shanghai Stock Exchange on June 16, 2004 (code: 600420, referred to as Sinopharm Hyundai). In April 2010, he joined China Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Sino Pharmaceutical Group"). Sinopharm Modern serves the national strategy of "Healthy China", with the development goal of achieving innovation-driven, sustainable development, strengthening, improving and expanding state-owned capital, and building high-quality chemical pharmaceuticals as the main body, and biopharmaceuticals and big health as the two wings." The strategic pattern is the focus of the task, adhere to the corporate philosophy of Sinopharm Group's "protecting life and caring for health", focuses on the five major areas of "anti-infection, cardiovascular and cerebrovascular, anti-tumor and immune regulation, metabolism and endocrine, and anesthesia spirit", and coordinates and optimizes the industrial layout. With multi-wheel drive, we are committed to becoming an innovation-driven and cutting-edge pharmaceutical company, and becoming a dynamic, powerful and influential industry guide. Sinopharm Modern is positioned as a unified chemical pharmaceutical industry under Sinopharm Group The platform has 23 wholly owned and controlled subsidiaries, including 15 second-level subsidiaries and 8 third-level subsidiaries. It has formed a professional with unified strategic integrity, concentrated resources, reasonable allocation, scale effect and industrial chain linkage effect The strategic development pattern of the main business revenue exceeds 10 billion.

Allergan

Loestrin is a popular birth control pill produced by Allergan, a global pharmaceutical company. It combines ethinyl estradiol with norethindrone, offering a reliable method of contraception.

Johnson & Johnson

Ortho Tri-Cyclen is a triphasic birth control pill manufactured by Johnson & Johnson. It uses a combination of ethinyl estradiol and norgestimate to prevent pregnancy.